Real-world prescribing in accordance to ACC/AHA guidelines for lipid-lowering therapy in high-risk primary and secondary prevention of ASCVD

Real-world prescribing in accordance to ACC/AHA guidelines for lipid-lowering therapy in high-risk primary and secondary prevention of ASCVD

Objective: The value of lipid lowering therapy (LLT) for prevention of atherosclerotic cardiovascular disease (ASCVD) is well understood. American College of Cardiology and American Heart Association guidelines recommend statin therapy for secondary and high-risk primary ASCVD prevention. Prior stud...

Full description

Saved in:
Bibliographic Details
Main Authors: Jonathan Arnold, Deeksha Acharya, Hetal Boricha, Himal Chapagain, Aleesha Kainat, Allison Bradley, Jong-Hyeon Jeong, Kevin A. Townsend, Mohammad B. Ateya, David A. DeMicco, YousefAlish, Michael J. Becich, Cynthia H. Chuang, Soledad A. Fernandez, Daniel E. Ford, Wenke Hwang, H. Lester Kirchner, Richard Morgan, Anuradha Paranjape, Neena A. Thomas, David A. Williams, RozelleHegeman-Dingle, Euan McLeod, Phillip A. Saccone, Kathleen M. McTigue
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:American Journal of Preventive Cardiology
Subjects:
Real-world evidence
Lipid lowering therapy
Cardiovascular diseases
Primary prevention
Secondary prevention
Statins
Online Access:http://www.sciencedirect.com/science/article/pii/S2666667725001424
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items